Atrial fibrillation as presenting sign of primary aldosteronism: results of the Prospective Appraisal on the Prevalence of Primary Aldosteronism in Hypertensive (PAPPHY) Study-Reference-Cited by-同舟云学术

Atrial fibrillation as presenting sign of primary aldosteronism: results of the Prospective Appraisal on the Prevalence of Primary Aldosteronism in Hypertensive (PAPPHY) Study

Published:2020-02 Issue:2 Volume:38 Page:332-339
ISSN:0263-6352
Container-title:Journal of Hypertension
language:en
Short-container-title:

Author:

Seccia Teresa M.,Letizia Claudio,Muiesan Maria L.,Lerco Silvia,Cesari Maurizio,Bisogni Valeria,Petramala Luigi,Maiolino Giuseppe,Volpin Roberta,Rossi Gian Paolo

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine,Physiology,Internal Medicine

Reference38 articles.

1. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS;Kirchhof;Eur Heart J,2016

2. 50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort study;Schnabel;Lancet,2015

3. Edoxaban versus warfarin in patients with atrial fibrillation;Giugliano;N Engl J Med,2013

4. Dabigatran versus Warfarin in Patients with Atrial Fibrillation;Connolly;N Engl J Med,2009

5. Influence of systolic and diastolic blood pressure on the risk of incident atrial ribrillation in women;Conen;Circulation,2009

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Management of Primary Aldosteronism: An Update;Hypertension;2024-09

2. 2024 ESC Guidelines for the management of elevated blood pressure and hypertension;European Heart Journal;2024-08-30

3. Aldosterone Effect on Cardiac Structure and Function;Current Cardiology Reviews;2024-07

4. Adverse Effects of Aldosterone: Beyond Blood Pressure;Journal of the American Heart Association;2024-04-02

5. Role of the CCL5 and Its Receptor, CCR5, in the Genesis of Aldosterone-Induced Hypertension, Vascular Dysfunction, and End-Organ Damage;Hypertension;2024-04